GlassScriptPhysician profile
Patience H Reading
NPI 1902860976
$706.92
in general payments reported to CMS, 2019-2025
19 companies · $107 in 2025
The $107 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.05 · 2020: $19.33 · 2021: $210 · 2022: $136 · 2023: $77.78 · 2024: $145 · 2025: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $329.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $329.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $164.83 | 2020-2025 | |
| Pfizer INC. | $71.58 | 2023-2025 | |
| Abbvie INC. | $49.24 | 2021-2022 | |
| Genzyme Corporation | $47.73 | 2021 | |
| Amgen INC. | $43.68 | 2021-2022 | |
| Ge Healthcare | $42.35 | 2021-2025 | |
| Abbott Laboratories | $35.96 | 2019-2024 | Jot Dx |
| Biogen, INC. | $34.72 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $32.60 | 2021 | |
| Emd Serono, INC. | $30.38 | 2021 | |
| Allergan, INC. | $19.32 | 2022 | |
| Neurelis, INC. | $19.31 | 2021 | |
| Lilly USA, LLC | $18.17 | 2021 | |
| Hospira, INC. | $16.82 | 2024 | |
| Teva Pharmaceuticals USA, INC. | $16.73 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $16.47 | 2022 | |
| Boston Scientific Corporation | $16.45 | 2023 | Vercise |
| Argenx US, INC. | $16.23 | 2024 | Vyvgart Hytrulo |
| Ucb, INC. | $14.35 | 2024 | Rystiggo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patience Reading listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.